業績紹介
2008年 論文
- Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
Mikami S, Oya M, Shimoda M, Mizuno R, Ishida M, Kosaka T, Mukai M, Nakajima M, Okada Y.
Clin Cancer Res. 2008 Oct 1;14(19):6055-61. doi: 10.1158/1078-0432.CCR-08-0750. Epub 2008 Sep 22. - Angiomyolipoma with epithelial cysts of the kidney in a man.
Mikami S, Oya M, Mukai M.
Pathol Int. 2008 Oct;58(10):664-7. - Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy.
Kanai K, Kikuchi E, Ohigashi T, Miyajima A, Nakagawa K, Nakashima J, Oya M.
Int J Clin Oncol. 2008 Dec;13(6):510-4. doi: 10.1007/s10147-008-0779-x. Epub 2008 Dec 18. - The novel NF-kappaB activation inhibitor dehydroxymethyl-epoxyquinomicin suppresses anti-Thy1.1-induced glomerulonephritis in rats.
Kosaka T, Miyajima A, Kikuchi E, Horiguchi Y, Umezawa K, Ohigashi T, Nakashima J, Asano T, Oya M.
Nephron Exp Nephrol. 2008;110(1):e17-24. - Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.
Kanao K, Mikami S, Mizuno R, Shinojima T, Murai M, Oya M.
J Urol. 2008 Sep;180(3):1131-6. - The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.
Ide H, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M.
Jpn J Clin Oncol. 2008 May;38(5):360-4. - Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
Ozu C, Nakashima J, Horiguchi Y, Oya M, Ohigashi T, Murai M.
Int J Urol. 2008 May;15(5):419-22. - Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
Nishimoto K, Nakashima J, Hashiguchi A, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Oya M, Murai M.
Int J Urol. 2008 Jun;15(6):520-3. - Simple stratification of survival using bone scan and serum C-reactive protein in prostate cancer patients with metastases.
Nakashima J, Kikuchi E, Miyajima A, Nakagawa K, Oya M, Ohigashi T, Murai M.
Urol Int. 2008;80(2):129-33. - Papillary renal cell carcinoma: clinicopathological characteristics in 40 patients.
Kosaka T, Mikami S, Miyajima A, Kikuchi E, Nakagawa K, Ohigashi T, Nakashima J, Oya M.
Clin Exp Nephrol. 2008 Jun;12(3):195-9. - Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case report.
Kosaka T, Mikami S, Miyajima A, Oya M.
Clin Exp Nephrol. 2008 Apr;12(2):155-158.
